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For information regarding this article, E-mail: ipeltan@uw.edu An International Normalized Ratio-Based Definition of Acute Traumatic Coagulopathy Is Associated With Mortality, Venous Thromboembolism, and Multiple Organ Failure After Injury Uncontrolled hemorrhage causes many of these deaths, particularly in the immediate postinjury phase (4, 5) . Hemorrhage contributed to 42% of all deaths in a recent multicenter observational study of severely injured patients, including 67% of deaths within the first 24 hours and 81% of deaths within 6 hours of injury (6) . Remediable factors that contribute to bleeding, such as coagulopathy, are therefore important therapeutic targets.
"Traditional" trauma-induced coagulopathy arises relatively late in the course of care (7) . By contrast, acute traumatic coagulopathy (ATC) is an early-onset syndrome of postinjury coagulopathy characterized by endogenously deranged clotting function present at admission to the emergency department (ED) (8, 9) . Widely recognized only in the past decade, ATC affects 20-30% of severely injured patients and is associated with an increased risk of death and multiple organ failure (MOF) (8) (9) (10) (11) (12) .
The literature characterizing ATC as a distinct condition has several limitations. Many of the descriptions of ATC were conducted at a single center or were retrospective evaluations of registry data. Control for confounding in evaluating the association of ATC with outcomes was incomplete in most studies. Most importantly, there is no consensus regarding the laboratory definition of the condition. Studies to date use conventional coagulation tests (prothrombin time [PT] or international normalized ratio [INR] , partial thromboplastin time [PTT], platelet count, thrombin time, and fibrinogen level) as well as nonstandard modifications of these values (PT ratio, Quick value, and PTT ratio) at varying thresholds and in varying combinations to define ATC ( Table 1) . Thromboelastography, a viscoelastic assay of clot formation and lysis in whole blood, may provide more rapid results and better simulate in vivo coagulation than conventional coagulation tests (13) (14) (15) . However, aside from transfusion requirements, the literature linking one or more viscoelastic parameters to clinically meaningful trauma outcomes is limited (16, 17) . Problems of availability, reliability, complexity of interpretation, and limited interchangeability of commercially available systems further hinder the use of thromboelastography to define ATC and, more generally, its routine use in trauma care (18, 19) .
An ideal definition of ATC would identify a clinically distinct subset of trauma patients using a laboratory test that is widely available, low cost, standardized globally, and easily interpreted by practitioners. Although the INR meets these laboratory criteria, it is unclear (1) whether INR as a single test measured on ED admission and reflective of extrinsic coagulation pathway abnormalities is independently associated with adverse outcomes and (2) which of the two most common INR-based ATC definitions-INR greater than 1.2 (equivalent to PT, Quick value, or INR outside the normal range [9, 10, [20] [21] [22] [23] [24] ) or INR greater than 1.5 (25-28)-are most clinically meaningful. To address these issues, we investigated the independent association of INR with mortality and morbidity in a prospective multicenter cohort of severely injured trauma patients. We then compared the adjusted association of ATC and adverse trauma outcomes resulting from these two candidate ATC definitions.
MATERIALS AND METHODS
We obtained deidentified data from a multicenter prospective cohort study (Inflammation and the Host Response to Injury Consortium). In brief, the study enrolled blunt trauma patients presenting to one of nine U.S. level I trauma centers from 2003 to 2010 who (1) exhibited shock within 60 minutes of ED arrival, defined as a base deficit of 6 mEq/L or greater or systolic blood pressure (SBP) less than 90 mm Hg (2); had any non-head abbreviated injury score (AIS) of 2 or greater; and (3) required red blood cell transfusion within 12 hours. Exclusion criteria were severe traumatic brain injury (AIS head ≥ 4 or score ≤ 3 for the motor component of the Glasgow Coma Scale [GCS] by 24 hr after injury); age 16 years or younger or 90 years or older; and complete cervical spine injury. Additional details regarding participating centers and the aims of this research study are provided at www.gluegrant. org. For the present study, we excluded patients who were not directly admitted to the participating trauma center from the field, who were on warfarin, or who received prehospital blood transfusions. The initial study was approved by the institutional review boards of each participating institution. Use of deidentified data for the current study was determined to be exempt from review by the University of Washington Institutional Review Board.
Clinical care was standardized across the participating hospitals (29) (30) (31) (32) (33) (34) (35) (36) (37) . Trained research nurses abstracted the data, with verification by independent abstraction and by central review. Subjects were monitored until discharge or postinjury day 28 for a range of post-trauma complications using standardized definitions (38) . Acute respiratory distress syndrome (ARDS) was defined in accordance with the 1994 American-European Consensus Conference criteria as the acute onset of bilateral infiltrates on chest radiograph with Pao 2 /Fio 2 ratio less than 200 and no evidence of left-sided heart failure (39) . Venous thromboembolism (VTE) included pulmonary embolism (PE) or deep vein thrombosis (DVT). PE was diagnosed by angiography, CT scan, or moderate-or high-probability ventilation/perfusion scan. DVT was identified in the extremities or pelvis on autopsy, venogram, or noninvasive vascular evaluation. Hypotension was defined as SBP less than 90. MOF was defined as a Marshall multiple organ dysfunction score (40) , excluding the neurologic component, of at least 6 at least 48 hours after injury (41) .
Injury characteristics were defined using the International Classification of Diseases, 9th revision, diagnosis codes recorded for each subject as previously described (42) : femur fracture (any 820.x and/or 821.x code); flail chest (807.4); pulmonary contusion (807.4, 807.13-19, and/or 861.x); pelvic fracture (any one of 808.x [except 808.2, stable pelvic fracture]); and spinal cord injury (any one of 806.x and/or 952.x). Massive transfusion was defined as receipt of 10 units or greater of packed red blood cells within 24 hours of ED admission.
We examined all-cause in-hospital mortality and hemorrhagic shock-associated in-hospital mortality as primary endpoints in this study. We evaluated the association of INR (modeled as a continuous variable) with these endpoints using multivariable logistic regression adjusted for potential confounders. We also examined the adjusted association of admission INR (as a continuous variable) and several secondary outcomes (MOF, ARDS, and VTE) using Cox proportional hazard analysis to account for the competing risk of mortality. Selection of adjustment variables for each model occurred a priori based on literature review (10) (11) (12) (42) (43) (44) (45) (46) (47) . Subjects with incomplete data for adjustment variables were excluded from the primary analyses but included in multiply imputed sensitivity analyses (see below). Validity of the proportional hazards assumption for each model was checked according to the method of Grambsch and Therneau (48) . We next examined the risk-adjusted association between ATC, modeled as one of two candidate dichotomous exposures, and the outcomes significantly associated with INR when it was modeled as a continuous variable. As a result, we evaluated two risk-adjusted models for each outcome, differing as to the ATC definition but otherwise containing the same covariates. We selected the two candidate ATC definitions, INR greater than 1.2 or INR greater than 1.5, based on the INR thresholds most frequently used in published literature to define ATC (9, 10, (20) (21) (22) (23) (24) (25) (26) (27) (28) . We compared the fit of the two competing models for each outcome using the Akaike information criterion (49) .
We performed four sensitivity analyses for the association of INR with mortality outcomes. First, to determine whether the most severe INR derangements were skewing our analysis, we reestimated the logistic regression models after exclusion of subjects with admission INRs greater than 2 sds above the mean. Second, to investigate whether the omission of cases with missing data introduced bias, we repeated our regression analyses after performing multiple imputation to account for missing data, using chained equations to create 50 imputed data sets (50) . Missing values for admission INR, base deficit, temperature, body mass index, and prehospital GCS and IV fluid volume were imputed using predictive mean matching (51) from three nearest neighbors. Admission hypotension was imputed using logistic regression. Variables in the imputation models included the above missing variables, covariates from each logistic regression and Cox regression model, and outcome variables for all-cause and bleeding-associated mortality, ARDS, VTE, and MOF. The analyses of imputed data were repeated after excluding subjects with imputed INR data. Finally, because INR was recorded to two decimal place accuracy for some but not all subjects, a small fraction of subjects were differently classified using INR greater than 1.2 versus INR 1.3 or greater as the lower-threshold ATC definition. We therefore evaluated whether using an INR 1.3 or greater rather than INR greater than 1.2 for the lower-threshold ATC definition altered our findings.
Data analysis was performed using Stata version 13.1 (StataCorp LP, College Station, TX). For univariate analysis, continuous variables were compared using unpaired t tests with unequal variance or Mann-Whitney tests as appropriate. Categorical variables were compared using chi-square tests. Tests of significance in multivariable analysis used the Wald test. Odds ratios (OR) and hazard ratios are reported with 95% CIs based on robust ses clustered on center to allow for correlation within centers. A p value of 0.05 or less was considered significant.
RESULTS
Of 2,007 subjects entered in the Inflammation and Host Response to Injury database, 1,373 met inclusion criteria for the current study ( Fig. 1) . Of those, 342 (25%) had missing data for one or more covariates in the prespecified multivariable model for the primary outcomes. Initial ED temperature was the most frequent missing data element (222 subjects), followed by missing INR values and other covariate data elements (each representing approximately ≤5% of the eligible cohort). Demographic and other injury characteristics for the 1,031 subjects with complete data for the primary analysis are shown in Table 2 . The majority of subjects (88.1%) were white and 14.0% were Hispanic. Most injuries resulted from motor vehicle collisions (52.9%), motorcycle collisions (15.9%), or pedestrians being struck by moving vehicles (15.7%). Overall, 153 subjects (14.8%) died, with 29% of deaths due in whole or part to hemorrhage ( Table 3) . Compared with subjects with complete data for the primary analysis, subjects with missing data were similar in age, prehospital blood pressure and GCS, admission INR, injury severity, and prevalence of VTE and MOF (Table S1, Supplemental Digital Content 1, http://links.lww.com/CCM/B260). Subjects with missing data received less prehospital IV fluid, exhibited higher admission temperatures and base deficits, experienced more shock on ED arrival, and had a higher prevalence of all-cause and hemorrhage-associated death, ARDS, and massive transfusion.
After adjustment for age, injury severity score, Acute Physiology and Chronic Health Evaluation II score, time from injury to ED arrival, shock, temperature and base deficit on ED arrival, and prehospital GCS and IV fluid volume, INR was associated with significantly increased odds of all-cause mortality ( Table 4 ). INR was also significantly associated with death caused primarily or in part by hemorrhagic shock ( increased more steeply at higher INRs (Fig. 2) . Increasing INR was also associated with a small but significantly increased risk of incident MOF and VTE but not ARDS (Table 4 ).
Admission INR was greater than 1.2 in 519 subjects (50.3%) and greater than 1.5 in 219 subjects (21.2%). In bivariate analyses, coagulopathy by either definition was associated with increased risk of all-cause mortality and death associated with hemorrhagic shock (Table 3 ). Massive transfusion, ARDS, VTE, and MOF were more common in coagulopathic subjects by either definition. The increased risks were more marked using the INR greater than 1.5 threshold than the INR greater than 1.2 threshold. For instance, 18.5% of subjects with INR greater than 1.2 died in hospital compared with 11.1% with INR 1.2 or less (crude relative risk [RR], 1.66; 95% CI, 1.23-2.25), whereas 26.5% of subjects with INR greater than 1.5 died compared with 11.7% with INR 1.5 or less (RR, 2.26; 95% CI, 1.69-3.03). Coagulopathic subjects also spent more time in the hospital, in the ICU, and receiving mechanical ventilation.
We next used multivariable logistic regression to compare the adjusted association between mortality outcomes and ATC defined as INR greater than 1.2 or INR greater than 1.5 ( Table 5 ). The adjusted risk of all-cause death (OR, 1.88; 95% CI, 1.36-2.60) was significantly elevated in subjects with ATC as defined by INR greater than 1.5 (p < 0.001) compared with subjects without ATC (INR ≤ 1.5), but not when INR was dichotomized at 1.2 (OR, 1.29; 95% CI, 0.92-1.82; p = 0.14). The Akaike information criterion was lower in the model using INR greater than 1.5 (658) than the model dichotomizing INR as greater than 1.2 versus 1.2 or less (663), indicating better model fit with the higher INR threshold. The adjusted risk of death due to hemorrhagic shock was significantly elevated in subjects with ATC defined as INR greater than 1.5 compared with those with an INR 1.5 or less (OR, 2.44; 95% CI, 1.43-4.18; p = 0.001). The risk was not significantly different between subjects with an INR greater than 1.2 compared with those with an INR 1.2 or less (OR, 1.58; 95% CI, 0.83-3.02; p = 0.16). As observed for all-cause mortality, the AIC was lower for the model using ATC defined as an INR greater than 1.5 (285) than for the model defining ATC as an INR greater than 1.2 (289).
Excluding subjects with INR greater than 2 sds above the mean did not alter our findings regarding the association between candidate ATC definitions and all-cause or hemorrhage-associated death ( In adjusted analyses, the presence of ATC was significantly associated with VTE when defined as INR greater than 1.5 but not when defined as INR greater than 1.2 ( Table 5 ). For MOF, the magnitude of the adjusted association was similar for INR greater than 1.5 and INR greater than 1.2, but only the association with INR greater than 1.5 was statistically significant.
We conducted an exploratory analysis of the adjusted risk of death or death due to hemorrhagic shock among individuals with mildly elevated admission INR (Table S6 , Supplemental Digital Content 6, http://links.lww.com/CCM/ B265). Admission INR was greater than 1.2 and 1.5 or less in 30% (n = 300). Compared with patients with INR 1.2 or less, there was no increased risk of death (OR, 1.01; 95% CI, 0.7-1.44) or death due to hypovolemic shock (OR, 1.20; 95% CI, 0.59-2.45).
DISCUSSION
In a well-described, multicenter cohort of patients with severe injuries, we confirmed that prolonged admission INR is a risk factor for all-cause and hemorrhage-associated mortality, VTE, and MOF after adjustment for known and plausible confounders. Whereas INR greater than 1.2 was not associated with trauma mortality or morbidity, ATC diagnosed using an admission INR greater than 1.5 identified a subset of patients who, adjusting for other factors, were at increased risk of death, VTE, and MOF.
Prolonged PT early after injury correlates strongly with injury severity score, shock, and acidosis (11) , raising the possibility that an abnormal PT (or a derivative) is simply a marker of overall injury severity instead of a biological mechanism for adverse outcomes. Many prior studies did not control confounding rigorously enough when examining the association of ATC with death and other outcomes to exclude this chance. Our carefully controlled analysis of multicenter data provides evidence that an elevated admission INR is in fact an indicator of important abnormalities of the extrinsic coagulation pathway associated with these adverse outcomes.
Over the past decade, investigators have used variable and sometimes complex laboratory criteria to define the syndrome of ATC. ATC definitions based solely on prolonged PT or its derivatives but are increasingly common among studies using conventional coagulation tests ( Table 1 ). The lack of consensus on how to define ATC remains a barrier to the study and treatment of ATC as a distinct condition. We therefore compared the ability of two candidate INR-based definitions of ATC to identify injured patients at risk for adverse outcomes. Our data support diagnosing ATC when INR is greater than 1.5 on ED admission. Strengths of this definition include its simplicity and generalizability, features that facilitate its application in both community hospitals and low-resource settings. An INR-based ATC definition offers advantages over definitions using the PT or PT ratio because (1) INR is directly reported by the laboratory and (2) INR corrects for variability in the PT ratio over time and between laboratories (52). Although we were unable to evaluate definitions using PTT, platelet count, or fibrinogen level, these parameters alone are insensitive for clinically significant coagulopathy and unlikely to markedly improve an INRbased definition (9, 26, (53) (54) (55) . Viscoelastic assays' speed, ability to simulate in vivo clotting, and usage for mechanistic studies of acute coagulopathy make them attractive (14) , but data linking specific functional abnormalities detected by these tests to trauma outcomes are too limited to base ATC diagnosis on this technology (56) (57) (58) . An INR-based definition of ATC offers a reproducible, laboratory-based definition with low institutional and geographic variability, facilitating future clinical and translational research studies and ATC intervention trials.
Defining ATC based on a single conventional coagulation test also has several potential problems. Logistically, the delay from collection to result may limit these tests usage in fast-paced trauma care (19) . Application of point-of-care INR testing could overcome this obstacle, but this method has so far proven unsatisfactory in the trauma setting (19) . More broadly, as a plasma-based test, INR reflects quantitative deficiencies in the "extrinsic" clotting pathway (factors V, VII, and X, prothrombin, and fibrinogen) under laboratory conditions rather than the cell-based clot formation that occurs in vivo (19) . Some physiologically important coagulation derangements present after trauma, such as hyperfibrinolysis, do not alter the PT/INR (59) . The INR alone cannot distinguish between potential ATC mechanisms. Recent studies using both conventional (60) and viscoelastic (28) measures suggest, however, that the PT/INR captures the most important type of coagulopathy for adverse trauma outcomes.
The risk-adjusted association we observed between elevated admission INR and later hypercoagulability is superficially paradoxical. Potential mechanisms include delayed initiation of VTE chemoprophylaxis (61), increased use of procoagulant therapies such as tranexamic acid in patients with ATC, or concurrent activation of anticoagulant and procoagulant pathways, with the balance shifting over time from a predominantly hypocoagulable to a predominantly hypercoagulable state (62) . Despite our attempts to adjust for known risk factors for post-traumatic VTE, the observed association could also result from residual confounding. Further studies are necessary to confirm this association and explore its mechanisms.
This study has several limitations. First, as with all observational studies, the observed association may not be causal. We made aggressive efforts to control for potential confounding factors in the studied relations but possibly omitted some relevant risk factors. Second, our results may not be generalizable to less severely injured trauma patients. We suspect, however, that ATC is more frequent and entails more severe ramifications in patients with severe injuries. Third, although standard operating procedures implemented across the participating institutions should have limited variations in care over time, changing transfusion strategies and other clinical practices may have altered the relation of INR with outcomes across the study period. Fourth, the candidate INR-based definitions of ATC are not mutually exclusive and therefore cannot be directly compared. Although it is possible that the risk we observed at INR greater than 1.5 was driven by subjects with more severe INR derangements, sensitivity analyses eliminating subjects with the most severely deranged INRs did not alter our results. We cannot exclude the possibility that a larger study with increased power to detect a small increased risk would have resulted in significant associations between INR greater than 1.2 and the studied outcomes. However, our exploratory analysis of subjects with mild INR elevations suggests that any increased risk of death detected among patients with INR greater than 1.2 would in fact be driven by the increased risk experienced by patients with INR greater than 1.5.
Finally, two groups of patients were excluded from our analysis. A substantial number of eligible subjects had missing covariate data, potentially influencing our multivariable analyses in an unpredictable manner. Although repetition of our analyses using multiply imputed data did not alter our conclusions, we cannot exclude a "missing not at random" pattern of missing data despite our use of a broad panel of covariates for imputation (63) . Our sensitivity analyses therefore reduce but do not eliminate the risk of bias due to missing data. In addition, we excluded the 29% of the enrolled subjects who initially received care at another facility before transfer to the study center because INR values on arrival to the first treating ED were unavailable. Although this approach was similar to past ATC studies, transfer patients may differ from patients directly admitted to level I trauma centers in important ways. Future studies are required that clarify the implications of ATC in this important and fairly large subset of trauma patients.
CONCLUSIONS
In this multicenter prospective cohort of severely injured trauma patients, we found that admission INR was associated with all-cause mortality, death due to bleeding, VTE, and MOF after controlling for other risk factors. An INR greater than 1.5 but not an INR greater than 1.2 identified a subset of trauma patients at increased risk for adverse outcomes. Defining ATC as an INR greater than 1.5 on ED admission provides a simple, generalizable, and clinically meaningful laboratory definition of ATC. Future studies should investigate methods to rapidly identify patients meeting this INR-based definition of ATC and determine the efficacy of targeted therapy for treatment of this severe complication of trauma.
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